RYTM · Rhythm Pharmaceuticals, Inc. · Share Buybacks
$115.02
+5.16 (+4.70%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$7.97B
Shares
69.33M
Volume · Nov 13
1.16M
Avg daily vol (3M)
997.95K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Key facts
CIK
1649904
CUSIP
76243J105
13F (30d)
263 filings
226 filers
Visit website
Investor relations